In our pursuit of critical federal support for celiac disease, we understand that true progress requires a multifaceted approach. While government support is invaluable, we also recognize the power of strategic collaboration with the private sector to drive the much-needed change our community deserves.
Continue ReadingThe Celiac Disease Foundation, a global leader in celiac disease patient advocacy, today announces its new relationship with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to provide resources for celiac disease patients and all consumers concerned about potential gluten in the company’s medications.
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...